Table 3 Myocardial T1ρ values and effect size under specific clinical conditions
Study population (n = Participants) | Healthy T1ρ value (ms) | Disease T1ρ values (ms) | Effect size (Cohen’s d) | References |
|---|---|---|---|---|
Chronic myocardial infarction (n = 21) | 54.0 ± 6.0 | 79.0 ± 11.0 | 2.8 | Van Oorschot et al. [82] |
Chronic myocardial infarction (n = 9) | 52.8 ± 1.8 | 82.4 ± 5.2 | 7.6 | Van Oorschot et al. [53] |
Hypertrophic cardiomyopathy (n = 18) | 42.5 ± 1.2 | NR | NR | Wang C et al. [81] |
Hypertrophic cardiomyopathy (n = 40) | 65.4 ± 5.2 | 72.2 ± 5.8 | 1.2 | Thompson et al. [80] |
Dilated cardiomyopathy (n = 20) | 51.5 ± 1.2 | 55.2 ± 2.7 | 1.5 | Van Oorschot et al. [56] |
End-stage renal disease (n = 32) | 49.4 ± 22.6 | 52.2 ± 4.0 | 0.2 | Wang L et al. [57] |